| 1 | Follicular cyst | 20.5% |
| 2 | Mucocele | 20.5% |
| 3 | Pancreatic Insufficiency | 20.5% |
| 4 | Pancreatitis | 20.5% |
| 5 | Pilonidal Cyst | 20.5% |
| 6 | Thyroglossal Cyst | 20.5% |
| 7 | Synovial Cyst | 20.5% |
| 8 | Dermoid Cyst | 17.6% |
| 9 | Pancreatic Fistula | 16.3% |
| 10 | Choledochal Cyst | 15.9% |
| 11 | Pancreatic Neoplasm | 15.7% |
| 12 | Lymphocele | 15.5% |
| 13 | Breast Cyst | 15.3% |
| 14 | Mediastinal Cyst | 15.3% |
| 15 | Parovarian Cyst | 15.3% |
| 16 | Pericardial Cyst | 15.3% |
| 17 | Thymic Cyst | 15.3% |
| 18 | Myxoid cyst | 15.3% |
| 19 | Digestive System Neoplasms | 14.3% |
| 20 | Pancreatitis, Chronic | 13.3% |
| 21 | Corpus Luteum Cyst | 12% |
| 22 | Ovarian Cysts | 12% |
| 23 | Biliary Tract Diseases | 11.9% |
| 24 | Gastrointestinal Diseases | 11.9% |
| 25 | Hamartoma | 11.9% |
| 26 | Liver diseases | 11.9% |
| 27 | Neoplasms, Hormone-Dependent | 11.9% |
| 28 | Neoplasms, Multiple Primary | 11.9% |
| 29 | Paraneoplastic Syndromes | 11.9% |
| 30 | Precancerous Conditions | 11.9% |
| 31 | Neoplasms, Second Primary | 11.9% |
| 32 | Peritoneal Neoplasms | 11.4% |
| 33 | Gastrointestinal Neoplasms | 11% |
| 34 | Liver neoplasms | 11% |
| 35 | Cystic Fibrosis | 10.5% |
| 36 | Congenital Hyperinsulinism | 10.1% |
| 37 | Pancreatitis, Alcoholic | 9.9% |
| 38 | Carcinoma, Pancreatic Ductal | 9.7% |
| 39 | Zollinger-Ellison syndrome | 9.4% |
| 40 | Esophageal Neoplasms | 9% |
| 41 | Neoplastic Processes | 8.9% |
| 42 | Neoplastic Syndromes, Hereditary | 8.9% |
| 43 | Pregnancy Complications, Neoplastic | 8.9% |
| 44 | Neoplasms, Experimental | 8.8% |
| 45 | Barrett Esophagus | 8.5% |
| 46 | Bile Duct Neoplasms | 8.3% |
| 47 | gallbladder neoplasm | 8.3% |
| 48 | Intestinal Neoplasms | 8.3% |
| 49 | Stomach Neoplasms | 8.3% |
| 50 | Liver Neoplasms, Experimental | 8.1% |
| 51 | insulinoma | 7.9% |
| 52 | Polycystic Ovary Syndrome | 7.9% |
| 53 | Multiple Endocrine Neoplasia | 7.8% |
| 54 | Gastrinoma | 7.8% |
| 55 | Glucagonoma | 7.8% |
| 56 | Vipoma | 7.7% |
| 57 | Hepatocellular Adenoma | 7.7% |
| 58 | Carcinoma 256, Walker | 7.6% |
| 59 | Carcinoma, Ehrlich Tumor | 7.6% |
| 60 | Carcinoma, Lewis Lung | 7.6% |
| 61 | Gastrointestinal Stromal Tumors | 7.3% |
| 62 | Colorectal Neoplasms | 7.1% |
| 63 | Adenomatous Polyposis Coli | 7% |
| 64 | Neoplasms, Radiation-Induced | 7% |
| 65 | Biliary cirrhosis | 6.9% |
| 66 | Paraneoplastic Encephalomyelitis | 6.8% |
| 67 | Mesenteric vascular insufficiency | 6.8% |
| 68 | Abdominal Neoplasms | 6.8% |
| 69 | Bile Duct Diseases | 6.8% |
| 70 | Cholelithiasis | 6.8% |
| 71 | Chylous Ascites | 6.8% |
| 72 | Erythroplasia | 6.8% |
| 73 | Esophageal Diseases | 6.8% |
| 74 | Fatty Liver | 6.8% |
| 75 | Gastroenteritis | 6.8% |
| 76 | Head and Neck Neoplasms | 6.8% |
| 77 | Hepatitis | 6.8% |
| 78 | Portal Hypertension | 6.8% |
| 79 | Intestinal Diseases | 6.8% |
| 80 | leukemia | 6.8% |
| 81 | Liver Cirrhosis | 6.8% |
| 82 | Neoplasms, Germ Cell and Embryonal | 6.8% |
| 83 | Neoplasms, Glandular and Epithelial | 6.8% |
| 84 | Pneumoperitoneum | 6.8% |
| 85 | Soft Tissue Neoplasms | 6.8% |
| 86 | Stomach Diseases | 6.8% |
| 87 | Thoracic Neoplasms | 6.8% |
| 88 | Focal Nodular Hyperplasia | 6.8% |
| 89 | Germ Cell Cancer | 6.8% |
| 90 | Hepatic Insufficiency | 6.8% |
| 91 | Aberrant Crypt Foci | 6.8% |
| 92 | Steatohepatitis | 6.8% |
| 93 | Esophageal Atresia | 6.8% |
| 94 | Intestinal Atresia | 6.8% |
| 95 | Mesenteric Vascular Occlusion | 6.8% |
| 96 | Trophoblastic Neoplasms | 6.8% |
| 97 | Cecal Neoplasms | 6.7% |
| 98 | Duodenal Neoplasms | 6.7% |
| 99 | Intestinal Fistula | 6.7% |
| 100 | Leukemia, Experimental | 6.7% |
| 101 | Mammary Neoplasms, Experimental | 6.7% |
| 102 | Enterocutaneous Fistula | 6.7% |
| 103 | Dysentery | 6.7% |
| 104 | Enteritis | 6.7% |
| 105 | Enterocolitis | 6.7% |
| 106 | Esophageal and Gastric Varices | 6.7% |
| 107 | Esophagitis | 6.7% |
| 108 | Gastritis | 6.7% |
| 109 | Inflammatory Bowel Diseases | 6.7% |
| 110 | Neuroectodermal Tumors | 6.7% |
| 111 | Cholecystolithiasis | 6.7% |
| 112 | Neoplasms, Neuroepithelial | 6.6% |
| 113 | Gliomatosis cerebri | 6.6% |
| 114 | Nesidioblastosis | 6.6% |
| 115 | Melanoma, Experimental | 6.3% |
| 116 | Proctocolitis | 6.2% |
| 117 | Sarcoma, Experimental | 6% |
| 118 | Duodenitis | 5.9% |
| 119 | Ileitis | 5.9% |
| 120 | melanoma | 5.9% |
| 121 | Erosive Duodenitis | 5.9% |
| 122 | Carcinosarcoma | 5.8% |
| 123 | Colitis | 5.8% |
| 124 | Duodenogastric Reflux | 5.8% |
| 125 | Hemangiosarcoma | 5.8% |
| 126 | Leukemia L1210 | 5.8% |
| 127 | Leukemia P388 | 5.8% |
| 128 | lymphangiosarcoma | 5.8% |
| 129 | Peptic Ulcer | 5.8% |
| 130 | Proctitis | 5.8% |
| 131 | Choledocholithiasis | 5.8% |
| 132 | Acanthoma | 5.8% |
| 133 | Meningioma | 5.8% |
| 134 | Leukemia, Radiation-Induced | 5.6% |
| 135 | Appendiceal Neoplasms | 5.6% |
| 136 | Colonic Neoplasms | 5.6% |
| 137 | Rectal Neoplasms | 5.6% |
| 138 | Medulloblastoma | 5.6% |
| 139 | Tuberous Sclerosis | 5.5% |
| 140 | Basal Cell Nevus Syndrome | 5.5% |
| 141 | Rectal Fistula | 5.4% |
| 142 | Anal Fistula | 5.4% |
| 143 | Anus Neoplasms | 5.4% |
| 144 | Sigmoid Neoplasms | 5.4% |
| 145 | Endocrine Gland Neoplasms | 5.4% |
| 146 | Eye Neoplasms | 5.4% |
| 147 | Liver Diseases, Parasitic | 5.4% |
| 148 | Nervous System Neoplasms | 5.4% |
| 149 | Sarcoma 180 | 5.3% |
| 150 | Fatty Liver, Alcoholic | 5.3% |
| 151 | Hepatitis, Alcoholic | 5.3% |
| 152 | Liver Cirrhosis, Alcoholic | 5.3% |
| 153 | Adenoma, Acidophil | 5.2% |
| 154 | Ganglioneuroma | 5.2% |
| 155 | Glioma | 5.2% |
| 156 | Malignant Glioma | 5.2% |
| 157 | Multiple Endocrine Neoplasia Type 1 | 5.2% |
| 158 | Choriocarcinoma | 5.2% |
| 159 | Carcinoma, Lobular | 5.2% |
| 160 | Bone neoplasms | 5.2% |
| 161 | Hepatic Veno-Occlusive Disease | 5.2% |
| 162 | Leukoplakia | 5.2% |
| 163 | Peliosis Hepatis | 5.2% |
| 164 | Skin Neoplasms | 5.2% |
| 165 | Hematologic Neoplasms | 5.2% |
| 166 | Hepatopulmonary Syndrome | 5.2% |
| 167 | Anus, Imperforate | 5.1% |
| 168 | Gastrointestinal Hemorrhage | 5.1% |
| 169 | Hemoperitoneum | 5.1% |
| 170 | Hepatomegaly | 5.1% |
| 171 | Histiocytic Disorders, Malignant | 5.1% |
| 172 | Actinic keratosis | 5.1% |
| 173 | Mesenteric Panniculitis | 5.1% |
| 174 | Neoplasm Invasiveness | 5.1% |
| 175 | Neoplasm Metastasis | 5.1% |
| 176 | Neoplasm Recurrence, Local | 5.1% |
| 177 | Panniculitis, Peritoneal | 5.1% |
| 178 | Peritonitis | 5.1% |
| 179 | Splenic Neoplasms | 5.1% |
| 180 | Peritoneal Fibrosis | 5.1% |
| 181 | Carcinogenesis | 5.1% |
| 182 | Encapsulating Peritoneal Sclerosis | 5.1% |
| 183 | Anorectal Malformations | 5.1% |
| 184 | Metastasis | 5.1% |
| 185 | Biliary Fistula | 5% |
| 186 | Gastric Fistula | 5% |
| 187 | Hepatic Vein Thrombosis | 5% |
| 188 | Liver Abscess | 5% |
| 189 | Budd-Chiari Syndrome | 5% |
| 190 | Tuberculosis, Gastrointestinal | 5% |
| 191 | Peutz-Jeghers Syndrome | 5% |
| 192 | Basal cell carcinoma | 4.9% |
| 193 | Carcinoma, Papillary | 4.9% |
| 194 | Squamous cell carcinoma | 4.9% |
| 195 | Chondrosarcoma | 4.9% |
| 196 | Craniopharyngioma | 4.9% |
| 197 | Crohn Disease | 4.9% |
| 198 | Cystadenoma | 4.9% |
| 199 | Duodenal Obstruction | 4.9% |
| 200 | leiomyosarcoma | 4.9% |
| 201 | liposarcoma | 4.9% |
| 202 | Mesothelioma | 4.9% |
| 203 | synovial sarcoma | 4.9% |
| 204 | Neuroectodermal Tumor, Melanotic | 4.9% |
| 205 | Angiomyolipoma | 4.9% |
| 206 | Clear Cell Sarcoma of Soft Tissue | 4.9% |
| 207 | Alveolar Soft Part Sarcoma | 4.9% |
| 208 | Neuroendocrine Tumors | 4.9% |
| 209 | Enterocolitis, Neutropenic | 4.9% |
| 210 | Necrotizing Enterocolitis | 4.9% |
| 211 | Sarcoma, Myeloid | 4.9% |
| 212 | Carcinoma, Basal Cell | 4.9% |
| 213 | Carcinoid Tumor | 4.9% |
| 214 | Neurilemmoma | 4.9% |
| 215 | Hutchinson's Melanotic Freckle | 4.9% |
| 216 | Melanoma, Amelanotic | 4.9% |
| 217 | Pouchitis | 4.9% |
| 218 | Lymphomatoid Granulomatosis | 4.6% |
| 219 | Appendicitis | 4.6% |
| 220 | Thymoma | 4.6% |
| 221 | Leukemia, Plasma Cell | 4.6% |
| 222 | Parathyroid Neoplasms | 4.5% |
| 223 | Thyroid Neoplasm | 4.5% |
| 224 | Thyroid carcinoma | 4.5% |
| 225 | Astrocytoma | 4.5% |
| 226 | Ependymoma | 4.5% |
| 227 | oligodendroglioma | 4.5% |
| 228 | Ganglioglioma | 4.5% |
| 229 | gliosarcoma | 4.5% |
| 230 | Anaplastic astrocytoma | 4.5% |
| 231 | Anaplastic Oligodendroglioma | 4.5% |
| 232 | Cystadenocarcinoma | 4.5% |
| 233 | Duodenal Ulcer | 4.5% |
| 234 | Fibrosarcoma | 4.5% |
| 235 | Osteosarcoma | 4.5% |
| 236 | Peptic Ulcer Perforation | 4.5% |
| 237 | Gastric ulcer | 4.5% |
| 238 | Mucoepidermoid Carcinoma | 4.5% |
| 239 | Adenoma | 4.4% |
| 240 | Ameloblastoma | 4.4% |
| 241 | Angiokeratoma | 4.4% |
| 242 | Carcinoma | 4.4% |
| 243 | Cecal Diseases | 4.4% |
| 244 | Cholangitis | 4.4% |
| 245 | Cholecystitis | 4.4% |
| 246 | Cholestasis | 4.4% |
| 247 | Chordoma | 4.4% |
| 248 | Colonic Diseases | 4.4% |
| 249 | Common Bile Duct Diseases | 4.4% |
| 250 | Esophageal Stenosis | 4.4% |
| 251 | Hemangioma | 4.4% |
| 252 | hemangiopericytoma | 4.4% |
| 253 | Hepatitis, Chronic | 4.4% |
| 254 | Ileal Diseases | 4.4% |
| 255 | Intestinal Obstruction | 4.4% |
| 256 | Intestinal Perforation | 4.4% |
| 257 | Jejunal Diseases | 4.4% |
| 258 | Lymphangioma | 4.4% |
| 259 | Mesenchymoma | 4.4% |
| 260 | Nevus | 4.4% |
| 261 | Pneumatosis Cystoides Intestinalis | 4.4% |
| 262 | Rectal Diseases | 4.4% |
| 263 | Retroperitoneal Neoplasms | 4.4% |
| 264 | Gastric Dilatation | 4.4% |
| 265 | Teratoma | 4.4% |
| 266 | Liver Failure | 4.4% |
| 267 | Gastric outlet obstruction | 4.4% |
| 268 | Hepatoblastoma | 4.4% |
| 269 | Mixed Tumor, Mullerian | 4.4% |
| 270 | Germinoma | 4.4% |
| 271 | Teratocarcinoma | 4.4% |
| 272 | Angiofibroma | 4.4% |
| 273 | Cronkhite-Canada Syndrome | 4.4% |
| 274 | Non-alcoholic Fatty Liver Disease | 4.4% |
| 275 | Chronic active hepatitis | 4.4% |
| 276 | Intestinal Polyposis | 4.4% |
| 277 | Sarcoma | 4.4% |
| 278 | Epithelioma | 4.4% |
| 279 | Composite Lymphoma | 4.4% |
| 280 | Malignant Carcinoid Syndrome | 4.3% |
| 281 | Adenofibroma | 4.3% |
| 282 | Fibroadenoma | 4.3% |
| 283 | Malignant Fibrous Histiocytoma | 4.3% |
| 284 | Glioblastoma | 4.2% |
| 285 | Neuroblastoma | 4.2% |
| 286 | Glioblastoma Multiforme | 4.2% |
| 287 | Chemical and Drug Induced Liver Injury | 4.2% |
| 288 | Nephroblastoma | 4.1% |
| 289 | Bowen's Disease | 4.1% |
| 290 | Paraganglioma | 4.1% |
| 291 | Rhabdomyosarcoma | 4.1% |
| 292 | Giant Cell Tumor of Bone | 4.1% |
| 293 | Lymphoma | 4.1% |
| 294 | Retinoblastoma | 4% |
| 295 | Hepatorenal Syndrome | 4% |
| 296 | Ganglioneuroblastoma | 4% |
| 297 | Tracheal Neoplasms | 4% |
| 298 | Enterocolitis, Pseudomembranous | 3.9% |
| 299 | pseudomembranous colitis | 3.9% |
| 300 | Dysentery, Bacillary | 3.9% |
| 301 | Leukoplakia, Oral | 3.9% |
| 302 | Colonic Pseudo-Obstruction | 3.9% |
| 303 | Dermatofibrosarcoma | 3.9% |
| 304 | Dermatofibrosarcoma Protuberans | 3.9% |
| 305 | Paraneoplastic Cerebellar Degeneration | 3.8% |
| 306 | Liver Abscess, Amebic | 3.8% |
| 307 | Colitis, Ischemic | 3.7% |
| 308 | Pheochromocytoma | 3.6% |
| 309 | Alveolar rhabdomyosarcoma | 3.6% |
| 310 | Acoustic Neuroma | 3.6% |
| 311 | Hydatidiform Mole | 3.6% |
| 312 | Esophageal Perforation | 3.5% |
| 313 | Hepatitis, Animal | 3.5% |
| 314 | Hepatitis, Viral, Human | 3.5% |
| 315 | Intestinal Diseases, Parasitic | 3.5% |
| 316 | Endometrial Stromal Sarcoma | 3.5% |
| 317 | Carcinoid Heart Disease | 3.5% |
| 318 | Deglutition Disorders | 3.4% |
| 319 | Mouth Neoplasms | 3.4% |
| 320 | Central Nervous System Neoplasms | 3.4% |
| 321 | Vascular Neoplasms | 3.4% |
| 322 | Thymus Neoplasms | 3.4% |
| 323 | Porphyrias, Hepatic | 3.4% |
| 324 | Achlorhydria | 3.3% |
| 325 | Genital Neoplasms, Female | 3.3% |
| 326 | Liver Cirrhosis, Experimental | 3.3% |
| 327 | Plasmacytoma | 3.3% |
| 328 | Gastric Antral Vascular Ectasia | 3.3% |
| 329 | Neurofibrosarcoma | 3.3% |
| 330 | Malignant histiocytosis | 3.3% |
| 331 | Lymphatic Metastasis | 3.3% |
| 332 | Neoplasms, Unknown Primary | 3.3% |
| 333 | Peptic Ulcer Hemorrhage | 3.3% |
| 334 | Gastroparesis | 3.3% |
| 335 | Leukemic Infiltration | 3.3% |
| 336 | Breast Neoplasms, Male | 3.3% |
| 337 | Histiocytic sarcoma | 3.3% |
| 338 | Neoplasm Micrometastasis | 3.3% |
| 339 | Triple Negative Breast Neoplasms | 3.3% |
| 340 | Adenocarcinoma | 3.3% |
| 341 | Cholestasis, Extrahepatic | 3.3% |
| 342 | Biliary Dyskinesia | 3.3% |
| 343 | Carcinoma in Situ | 3.3% |
| 344 | Carcinoma, Transitional Cell | 3.3% |
| 345 | Cholangitis, Sclerosing | 3.3% |
| 346 | Colonic Diseases, Functional | 3.3% |
| 347 | Phyllodes Tumor | 3.3% |
| 348 | Dysgerminoma | 3.3% |
| 349 | Esophageal motility disorders | 3.3% |
| 350 | Fecal Incontinence | 3.3% |
| 351 | Fecal Impaction | 3.3% |
| 352 | Hemangioendothelioma | 3.3% |
| 353 | Intussusception | 3.3% |
| 354 | Lipoma | 3.3% |
| 355 | Mallory-Weiss Syndrome | 3.3% |
| 356 | Megacolon | 3.3% |
| 357 | Myoma | 3.3% |
| 358 | Myxoma | 3.3% |
| 359 | Neuroma | 3.3% |
| 360 | Papilloma | 3.3% |
| 361 | Pseudomyxoma Peritonei | 3.3% |
| 362 | Pyloric Stenosis | 3.3% |
| 363 | Seminoma | 3.3% |
| 364 | Thyroid Nodule | 3.3% |
| 365 | Liver Failure, Acute | 3.3% |
| 366 | Papillomatosis | 3.3% |
| 367 | Angiolipoma | 3.3% |
| 368 | Myelolipoma | 3.3% |
| 369 | Neoplasms, Bone Tissue | 3.3% |
| 370 | Neoplasms, Fibrous Tissue | 3.3% |
| 371 | Smooth Muscle Tumor | 3.3% |
| 372 | Adenomatosis, Pulmonary | 3.3% |
| 373 | Adenomatous Polyps | 3.3% |
| 374 | Carcinoma, Large Cell | 3.3% |
| 375 | Carcinoma, Small Cell | 3.3% |
| 376 | Acalculous Cholecystitis | 3.3% |
| 377 | Desmoplastic Small Round Cell Tumor | 3.3% |
| 378 | End Stage Liver Disease | 3.3% |
| 379 | Chondroma | 3.3% |
| 380 | Ileus | 3.3% |
| 381 | Enchondroma | 3.3% |
| 382 | Meconium ileus | 3.3% |
| 383 | Limbic Encephalitis | 3.3% |
| 384 | Lymphangioleiomyomatosis | 3.3% |
| 385 | Optic Nerve Glioma | 3.2% |
| 386 | Radicular Cyst | 3.1% |
| 387 | Hepatitis B, Chronic | 3% |
| 388 | Hepatitis C, Chronic | 3% |
| 389 | Lambert-Eaton Myasthenic Syndrome | 2.9% |
| 390 | Testicular Neoplasms | 2.9% |
| 391 | Prolactinoma | 2.8% |
| 392 | Growth Hormone-Secreting Pituitary Adenoma | 2.8% |
| 393 | Adrenal Gland Neoplasms | 2.7% |
| 394 | Genital Neoplasms, Male | 2.7% |
| 395 | Uveal Neoplasms | 2.7% |
| 396 | Massive Hepatic Necrosis | 2.7% |
| 397 | Adenoid Cystic Carcinoma | 2.7% |
| 398 | Esophageal Achalasia | 2.7% |
| 399 | fibroma | 2.7% |
| 400 | Fibromatosis | 2.7% |
| 401 | Anal Fissure | 2.7% |
| 402 | Intestinal Pseudo-Obstruction | 2.7% |
| 403 | Irritable Bowel Syndrome | 2.7% |
| 404 | Osteoblastoma | 2.7% |
| 405 | Osteoma | 2.7% |
| 406 | Rhabdomyoma | 2.7% |
| 407 | Superior Mesenteric Artery Syndrome | 2.7% |
| 408 | Chondromatosis | 2.7% |
| 409 | Adenocarcinoma, Clear Cell | 2.7% |
| 410 | Cholangiocarcinoma | 2.7% |
| 411 | Cervical Intraepithelial Neoplasia | 2.7% |
| 412 | Hemangioblastoma | 2.7% |
| 413 | Emphysematous Cholecystitis | 2.7% |
| 414 | Neurogenic Bowel | 2.7% |
| 415 | Sphincter of Oddi Dysfunction | 2.7% |
| 416 | Lymphoma, Extranodal NK-T-Cell | 2.7% |
| 417 | Anal Ulcer | 2.7% |
| 418 | Fascioliasis | 2.7% |
| 419 | Urologic Neoplasms | 2.7% |
| 420 | Echinococcosis, Hepatic | 2.7% |
| 421 | Melena | 2.7% |
| 422 | Sebaceous Gland Neoplasms | 2.7% |
| 423 | Spinal Neoplasms | 2.7% |
| 424 | Bone Marrow Neoplasms | 2.7% |
| 425 | Chemical and Drug Induced Liver Injury, Chronic | 2.7% |
| 426 | Reye Syndrome | 2.6% |
| 427 | Mesoblastic Nephroma | 2.6% |
| 428 | Hematemesis | 2.6% |
| 429 | Hodgkin Disease | 2.6% |
| 430 | Lymphoma, Non-Hodgkin | 2.6% |
| 431 | Opsoclonus-Myoclonus Syndrome | 2.6% |
| 432 | Leydig Cell Tumor | 2.6% |
| 433 | Hemorrhoids | 2.5% |
| 434 | Autoimmune hepatitis | 2.5% |
| 435 | Afferent Loop Syndrome | 2.5% |
| 436 | Celiac Disease | 2.5% |
| 437 | Meningeal Neoplasms | 2.5% |
| 438 | Short Bowel Syndrome | 2.5% |
| 439 | Sprue, Tropical | 2.5% |
| 440 | Steatorrhea | 2.5% |
| 441 | Rectocele | 2.5% |
| 442 | Sprue | 2.5% |
| 443 | Diverticulitis | 2.5% |
| 444 | Dumping Syndrome | 2.5% |
| 445 | Leukemia, Myelomonocytic, Chronic | 2.5% |
| 446 | Rectal Prolapse | 2.5% |
| 447 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2.5% |
| 448 | Fibromatosis, Aggressive | 2.5% |
| 449 | Fibromatosis, Abdominal | 2.5% |
| 450 | Klatskin Tumor | 2.5% |
| 451 | granulosa cell tumor | 2.4% |
| 452 | Carcinoma, Ovarian Epithelial | 2.4% |
| 453 | Adrenocortical carcinoma | 2.3% |
| 454 | Myelitis, Transverse | 2.3% |
| 455 | Nose Neoplasms | 2.3% |
| 456 | Palatal Neoplasms | 2.3% |
| 457 | Primary amyloidosis | 2.2% |
| 458 | Variegate Porphyria | 2.2% |
| 459 | Acute intermittent porphyria | 2.2% |
| 460 | Porphyria Cutanea Tarda | 2.2% |
| 461 | Denys-Drash Syndrome | 2.1% |
| 462 | Hepatitis, Viral, Animal | 2.1% |
| 463 | Mastocytoma | 2.1% |
| 464 | Pruritus Ani | 2.1% |
| 465 | Ear Neoplasms | 2% |
| 466 | Eyelid Neoplasms | 2% |
| 467 | Giardiasis | 2% |
| 468 | Lung Neoplasms | 2% |
| 469 | Pleural Neoplasms | 2% |
| 470 | Hepatitis E | 2% |
| 471 | Meningeal Carcinomatosis | 2% |
| 472 | Mastocytosis, Systemic | 2% |
| 473 | Leukemia, Myeloid, Chronic-Phase | 2% |
| 474 | Renal Cell Carcinoma | 2% |
| 475 | Papillary Renal Cell Carcinoma | 2% |
| 476 | Hepatitis B | 2% |
| 477 | Hepatitis C | 2% |
| 478 | Mastocytosis | 2% |
| 479 | Sturge-Weber Syndrome | 2% |
| 480 | Xeroderma Pigmentosum | 2% |
| 481 | Pituitary Adenoma | 2% |
| 482 | Pituitary Neoplasms | 2% |
| 483 | Diverticulum | 2% |
| 484 | Hepatitis A | 2% |
| 485 | Diverticulosis | 2% |
| 486 | Cell Transformation, Viral | 2% |
| 487 | Brain Neoplasms | 2% |
| 488 | Salivary Gland Neoplasms | 2% |
| 489 | Spinal Cord Neoplasms | 2% |
| 490 | Tongue Neoplasms | 2% |
| 491 | Hemangioma, Cavernous | 2% |
| 492 | Hepatic Encephalopathy | 2% |
| 493 | Leukemia, T-Cell | 2% |
| 494 | Uterine Neoplasms | 2% |
| 495 | Vaginal Neoplasms | 2% |
| 496 | Vulvar Neoplasms | 2% |
| 497 | Uterine Cancer | 2% |
| 498 | Leukemia, B-Cell | 2% |
| 499 | Fallopian Tube Neoplasms | 2% |
| 500 | neurofibroma | 2% |
| 501 | Lymphoma, Follicular | 1.9% |
| 502 | T-Cell Lymphoma | 1.9% |
| 503 | Mantle cell lymphoma | 1.9% |
| 504 | Carcinoma, Endometrioid | 1.9% |
| 505 | ovarian neoplasm | 1.9% |
| 506 | Nasopharyngeal carcinoma | 1.9% |
| 507 | Laryngopharyngeal Reflux | 1.9% |
| 508 | Pharyngeal Neoplasms | 1.7% |
| 509 | Central Nervous System Cysts | 1.7% |
| 510 | Bronchial Neoplasms | 1.7% |
| 511 | Penile Neoplasms | 1.7% |
| 512 | Prostatic Neoplasms | 1.7% |
| 513 | Waldenstrom Macroglobulinemia | 1.7% |
| 514 | Multiple Myeloma | 1.7% |
| 515 | Multiple Pulmonary Nodules | 1.7% |
| 516 | Zellweger Syndrome | 1.6% |
| 517 | Lactose Intolerance | 1.6% |
| 518 | Polycythemia Vera | 1.6% |
| 519 | Supratentorial Neoplasms | 1.6% |
| 520 | Endometrial Neoplasms | 1.6% |
| 521 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.6% |
| 522 | Leukemia, Large Granular Lymphocytic | 1.6% |
| 523 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.6% |
| 524 | Lymphoma, T-Cell, Cutaneous | 1.6% |
| 525 | Lymphoma, AIDS-Related | 1.6% |
| 526 | Enteropathy-Associated T-Cell Lymphoma | 1.6% |
| 527 | Primary Effusion Lymphoma | 1.6% |
| 528 | Hepatolenticular Degeneration | 1.5% |
| 529 | Dupuytren Contracture | 1.5% |
| 530 | Laryngeal neoplasm | 1.5% |
| 531 | Urticaria Pigmentosa | 1.5% |
| 532 | Brain Stem Neoplasms | 1.5% |
| 533 | Mycosis Fungoides | 1.4% |
| 534 | Lymphomatoid Papulosis | 1.4% |
| 535 | Plasmablastic lymphoma | 1.4% |
| 536 | Bladder Neoplasm | 1.4% |
| 537 | Kidney Neoplasm | 1.4% |
| 538 | Ureteral Neoplasms | 1.4% |
| 539 | Urethral Neoplasms | 1.4% |
| 540 | Hypopharyngeal Neoplasms | 1.4% |
| 541 | Pleural Effusion, Malignant | 1.4% |
| 542 | Hypopharyngeal Cancer | 1.4% |
| 543 | Choroid Plexus Papilloma | 1.4% |
| 544 | Parotid Neoplasms | 1.4% |
| 545 | Prostatic Neoplasms, Castration-Resistant | 1.4% |
| 546 | Nelson Syndrome | 1.3% |
| 547 | Cryptosporidiosis | 1.3% |
| 548 | Tonsillar Neoplasms | 1.2% |
| 549 | Cerebellar Neoplasms | 1.2% |
| 550 | Burkitt Lymphoma | 1.2% |
| 551 | Rift Valley Fever | 1.1% |
| 552 | Sezary Syndrome | 1% |
| 553 | Nasopharyngeal Neoplasms | 1% |
| 554 | CREST Syndrome | 1% |
| 555 | Paranasal Sinus Neoplasms | 0.9% |
| 556 | Maxillary Sinus Neoplasms | 0.8% |
